Wedbush Reiterates Outperform on Zura Bio, Maintains $15 Price Target

Benzinga Newsdesk www.benzinga.com Negative 80.4%

Neg 80.4% Neu 0% Pos 0%

Wedbush analyst Martin Fan reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and maintains $15 price target.

Comments

No comments yet. Be the first!